Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02740140 · ClinicalTrials.gov registry record

Epidemiology of H. Pylori Transmission

A clinical trial, sponsored by Stanford University.

Completed
Registry status
1,750
Enrollment target

NCT02740140: Completed study, sponsored by Stanford University.

NCT02740140 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,750 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02740140 has completed, sponsored by Stanford University.

COMPLETED
Registry status
1,750 participants
Enrollment target

Study Summary

This observational epidemiologic study with nested cross-sectional and longitudinal aims will evaluate host immune response to mixed chronic infections (Helicobacter pylori, latent tuberculosis, intestinal helminthiasis) in recent US immigrants.

Trial Details

FieldValue
Enrollment Target 1,750 participants
Start Date 2008-06
Est. Completion 2013-07
Stanford University

1,744 total trials

What the finished NCT02740140 record still lists

NCT02740140 is an observational study that tracks outcomes without assigning an intervention. Its 1,750 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02740140 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02740140 about?

NCT02740140 is a clinical study titled "Epidemiology of H. Pylori Transmission". This observational epidemiologic study with nested cross-sectional and longitudinal aims will evaluate host immune response to mixed chronic infections (Helicobacter pylori, latent tuberculosis, intestinal helminthiasis) in recent US immigrants.

What is the current status of trial NCT02740140?

This trial is currently completed. The enrollment target is 1,750 participants. The study started on 2008-06. Estimated completion is 2013-07.

Who is sponsoring clinical trial NCT02740140?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05934487 · 1,750 participants · NA

    PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • NCT06954337 · 1,750 participants · NA

    MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

  • NCT07183527 · 1,750 participants · NA

    Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

  • NCT07062172 · 1,753 participants · NA

    Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02740140, the US trial registry maintained by the National Library of Medicine. NCT02740140 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.